L A Pearce - JoVE Visualize

Showing results (11-20 of 34) with videos related to

Pageof 4

Sort By:

Molecular Immunology|December 1, 1996

Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidaseJ L Atwell, L A Pearce, M Lah, et al.

Journal of the American College of Cardiology|June 17, 1998

Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III InvestigatorsM Zabalgoitia, J L Halperin, L A Pearce, et al.

Protein Engineering|August 31, 2000

ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimersO Dolezal, L A Pearce, L J Lawrence, et al.

Biochemistry and Molecular Biology International|September 26, 1997

Linear gene fusions of antibody fragments with streptavidin can be linked to biotin labelled secondary molecules to form bispecific reagentsL A Pearce, G W Oddie, G Coia, et al.

Archives of Internal Medicine|November 1, 1990

Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillationW M Feinberg, J F Seeger, R F Carmody, et al.

The American Journal of Cardiology|March 11, 1999

Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiographyJ L Blackshear, M Zabalgoitia, G Pennock, et al.

Neurology|January 1, 1996

Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation InvestigatorsV T Miller, L A Pearce, W M Feinberg, et al.

Stroke|August 3, 2002

Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosisD C Anderson, L J Kappelle, M Eliasziw, et al.

Heart (British Cardiac Society)|May 17, 2005

Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillationG Y H Lip, L A Pearce, B S P Chin, et al.

Journal of the American College of Cardiology|January 15, 2000

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation InvestigatorsR G Hart, L A Pearce, R M Rothbart, et al.

Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:

Pageof 4

Molecular Immunology|December 1, 1996

Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidaseJ L Atwell, L A Pearce, M Lah, et al.

Journal of the American College of Cardiology|June 17, 1998

Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III InvestigatorsM Zabalgoitia, J L Halperin, L A Pearce, et al.

Protein Engineering|August 31, 2000

ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimersO Dolezal, L A Pearce, L J Lawrence, et al.

Biochemistry and Molecular Biology International|September 26, 1997

Linear gene fusions of antibody fragments with streptavidin can be linked to biotin labelled secondary molecules to form bispecific reagentsL A Pearce, G W Oddie, G Coia, et al.

Archives of Internal Medicine|November 1, 1990

Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillationW M Feinberg, J F Seeger, R F Carmody, et al.

The American Journal of Cardiology|March 11, 1999

Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiographyJ L Blackshear, M Zabalgoitia, G Pennock, et al.

Neurology|January 1, 1996

Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation InvestigatorsV T Miller, L A Pearce, W M Feinberg, et al.

Stroke|August 3, 2002

Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosisD C Anderson, L J Kappelle, M Eliasziw, et al.

Heart (British Cardiac Society)|May 17, 2005

Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillationG Y H Lip, L A Pearce, B S P Chin, et al.

Journal of the American College of Cardiology|January 15, 2000

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation InvestigatorsR G Hart, L A Pearce, R M Rothbart, et al.

Pageof 4